Investors Urged to Lead Geron Securities Fraud Class Action Lawsuit
On April 3, 2025, the prominent national law firm Faruqi & Faruqi, LLP announced the initiation of an investigation into potential securities fraud claims against Geron Corporation. Investors are reminded that they have until May 12, 2025, to assert their interest in becoming lead plaintiffs in a federal class action lawsuit targeting the company.
The firm specifically seeks to hear from individuals who lost more than $100,000 while holding Geron stock between February 28, 2024, and February 25, 2025. Those eligible to join this action should contact Faruqi & Faruqi partner Josh Wilson for guidance on their rights and options available to them. The law firm has a rich history of recovering hundreds of millions for investors since its inception in 1995, emphasizing its commitment to Securities Law and protection of investor rights.
The core of the allegations stems from claims that Geron and its executives allegedly made misleading statements regarding the development and potential of their drug, Rytelo. These statements suggested a strong confidence in the company’s ability to tap into a significant market need for their product while downplaying the associated risks and market challenges, such as seasonality and elasticity of demand that could impact sales.
On the heels of Geron's fourth-quarter financial announcement, it was reported on February 26, 2025, that Rytelo's growth had considerably stalled, attributed to a combination of factors including seasonality, lack of awareness about the drug, and the monitoring requirements that accompany its use. The share price plummeted, dropping 32.07% from $2.37 to $1.61 within just one day, as investors reacted to the sobering news. This sharp decline exemplifies the volatility and risks that investors face in such financial environments.
To establish a lead plaintiff in a class action lawsuit, it is necessary for involved investors to demonstrate that they are predominately affected by the issues at hand and can represent the interests of the entire class. Participants have a choice: they may actively involve themselves or opt to remain passive members of the class, with their recovery rights intact regardless of their level of involvement in the litigation. Legal counsel can assist in determining the best approach for individual shareholders.
Faruqi & Faruqi also encourages other stakeholders, including former employees or whistleblowers who have relevant information surrounding Geron’s operations, to come forward. Such insights could further bolster the case against the company, ensuring that accountability is upheld in the corporate landscape.
For further details on the Geron class action and to discuss your situation, you may visit www.faruqilaw.com/GERN. Interested parties can also reach out directly to Josh Wilson at Faruqi & Faruqi through the specified phone numbers. Updates and additional legal insights will also be available on their social media platforms including LinkedIn and Facebook. This serves as a critical period for investors affected by the potential misconduct as they strategize their next steps in pursuing justice and financial recovery.
In a fast-paced investment climate, it's crucial for shareholders to remain informed and proactive regarding their rights. The Faruqi & Faruqi law firm stands as a significant ally for investors navigating these turbulent waters, revealing the importance of legal guidance and comprehensive understanding of the securities laws at play. With the deadline approaching for filing claims, timely action is essential for those who wish to seek restitution in this ongoing legal matter.
The firm specifically seeks to hear from individuals who lost more than $100,000 while holding Geron stock between February 28, 2024, and February 25, 2025. Those eligible to join this action should contact Faruqi & Faruqi partner Josh Wilson for guidance on their rights and options available to them. The law firm has a rich history of recovering hundreds of millions for investors since its inception in 1995, emphasizing its commitment to Securities Law and protection of investor rights.
The core of the allegations stems from claims that Geron and its executives allegedly made misleading statements regarding the development and potential of their drug, Rytelo. These statements suggested a strong confidence in the company’s ability to tap into a significant market need for their product while downplaying the associated risks and market challenges, such as seasonality and elasticity of demand that could impact sales.
On the heels of Geron's fourth-quarter financial announcement, it was reported on February 26, 2025, that Rytelo's growth had considerably stalled, attributed to a combination of factors including seasonality, lack of awareness about the drug, and the monitoring requirements that accompany its use. The share price plummeted, dropping 32.07% from $2.37 to $1.61 within just one day, as investors reacted to the sobering news. This sharp decline exemplifies the volatility and risks that investors face in such financial environments.
To establish a lead plaintiff in a class action lawsuit, it is necessary for involved investors to demonstrate that they are predominately affected by the issues at hand and can represent the interests of the entire class. Participants have a choice: they may actively involve themselves or opt to remain passive members of the class, with their recovery rights intact regardless of their level of involvement in the litigation. Legal counsel can assist in determining the best approach for individual shareholders.
Faruqi & Faruqi also encourages other stakeholders, including former employees or whistleblowers who have relevant information surrounding Geron’s operations, to come forward. Such insights could further bolster the case against the company, ensuring that accountability is upheld in the corporate landscape.
For further details on the Geron class action and to discuss your situation, you may visit www.faruqilaw.com/GERN. Interested parties can also reach out directly to Josh Wilson at Faruqi & Faruqi through the specified phone numbers. Updates and additional legal insights will also be available on their social media platforms including LinkedIn and Facebook. This serves as a critical period for investors affected by the potential misconduct as they strategize their next steps in pursuing justice and financial recovery.
In a fast-paced investment climate, it's crucial for shareholders to remain informed and proactive regarding their rights. The Faruqi & Faruqi law firm stands as a significant ally for investors navigating these turbulent waters, revealing the importance of legal guidance and comprehensive understanding of the securities laws at play. With the deadline approaching for filing claims, timely action is essential for those who wish to seek restitution in this ongoing legal matter.
Topics Financial Services & Investing）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.